| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding Corp. (TNXP) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. TNXP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 39.0K | $475.9K | - | |
| CFO | 39.0K | $475.9K | - | |
| Other | 39.0K | $475.9K | - | |
| Other | 39.0K | $475.9K | - | |
| CEO | 20.0K | $244.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2018 | Lederman Seth | Chief Executive Officer | Buy | 500 | $4.64 | $2,320.00 | +2.9% | |
| Jun 28, 2018 | Lederman Seth | Chief Executive Officer | Buy | 500 | $4.58 | $2,290.00 | +3.0% | |
| Jun 27, 2018 | Lederman Seth | Chief Executive Officer | Buy | 500 | $4.55 | $2,275.00 | +3.1% | |
| Jun 25, 2018 | Mario Ernest | Director | Buy | 16,500 | $4.48 | $73,920.00 | +49.3% | |
| Jun 14, 2018 | Sullivan Gregory M | Chief Medical Officer | Buy | 10,000 | $3.97 | $39,650.00 | +95.4% | |
| Jun 14, 2018 | Saenger Bradley | Chief Financial Officer | Buy | 300 | $4.10 | $1,230.00 | +10.8% | |
| Jun 14, 2018 | Morris Jessica Edgar | Chief Operating Officer | Buy | 300 | $4.19 | $1,257.00 | +22.4% | |
| Jun 12, 2018 | Lederman Seth | Chief Executive Officer | Buy | 3,000 | $4.37 | $13,110.00 | +8.9% | |
| Jun 1, 2018 | Rhodes John B | Director | Buy | 7,500 | $3.33 | $24,975.00 | +47.0% | |
| May 25, 2018 | Lederman Seth | Chief Executive Officer | Buy | 4,000 | $3.17 | $12,680.00 | +17.6% |